Global Erectile Dysfunction Drugs Market Insights, Forecast to 2029

Publisher Name :
Date: 27-Sep-2023
No. of pages: 112
Inquire Before Buying

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

The global Erectile Dysfunction Drugs market is projected to grow from US$ 5171.1 million in 2023 to US$ 7335.2 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.

North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.

The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.

Report Includes:

This report presents an overview of global market for Erectile Dysfunction Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Erectile Dysfunction Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Erectile Dysfunction Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Erectile Dysfunction Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Erectile Dysfunction Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Erectile Dysfunction Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma and Seoul Pharma, etc.

By Company

- Eli Lilly

- Pfizer

- Bayer

- BaiYunShan General Factory

- S.K. Chemicals

- Teva Pharma

- Dong-A ST

- Metuchen Pharma

- Seoul Pharma

- CSBIO.

Segment by Type

- Sildenafil

- Tadalafil

- Others

Segment by Application

- Hospital Pharmacies

- Private Clinics

- Retail Pharmacies

- E-Commerce (B2B)

- E-Commerce (B2C)

Segment By Region

- US & Canada

- - U.S.

- - Canada

- China

- Asia (excluding China)

- - Japan

- - South Korea

- - China Taiwan

- Southeast Asia

- - India

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Middle East, Africa, Latin America

- - Brazil

- - Mexico

- - Turkey

- - Israel

- - GCC Countries

Chapter Outline

Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Erectile Dysfunction Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and By Region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erectile Dysfunction Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Erectile Dysfunction Drugs Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Erectile Dysfunction Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Erectile Dysfunction Drugs Revenue by Region
2.2.1 Global Erectile Dysfunction Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Erectile Dysfunction Drugs Revenue by Region (2018-2023)
2.2.3 Global Erectile Dysfunction Drugs Revenue by Region (2024-2029)
2.2.4 Global Erectile Dysfunction Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Erectile Dysfunction Drugs Sales by Region
2.4.1 Global Erectile Dysfunction Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Erectile Dysfunction Drugs Sales by Region (2018-2023)
2.4.3 Global Erectile Dysfunction Drugs Sales by Region (2024-2029)
2.4.4 Global Erectile Dysfunction Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Erectile Dysfunction Drugs Sales by Manufacturers
3.1.1 Global Erectile Dysfunction Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erectile Dysfunction Drugs in 2022
3.2 Global Erectile Dysfunction Drugs Revenue by Manufacturers
3.2.1 Global Erectile Dysfunction Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Drugs Revenue in 2022
3.3 Global Key Players of Erectile Dysfunction Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Erectile Dysfunction Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Erectile Dysfunction Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Erectile Dysfunction Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Erectile Dysfunction Drugs Sales by Type
4.1.1 Global Erectile Dysfunction Drugs Historical Sales by Type (2018-2023)
4.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2018-2029)
4.2 Global Erectile Dysfunction Drugs Revenue by Type
4.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Erectile Dysfunction Drugs Price by Type
4.3.1 Global Erectile Dysfunction Drugs Price by Type (2018-2023)
4.3.2 Global Erectile Dysfunction Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Erectile Dysfunction Drugs Sales by Application
5.1.1 Global Erectile Dysfunction Drugs Historical Sales by Application (2018-2023)
5.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2018-2029)
5.2 Global Erectile Dysfunction Drugs Revenue by Application
5.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Erectile Dysfunction Drugs Price by Application
5.3.1 Global Erectile Dysfunction Drugs Price by Application (2018-2023)
5.3.2 Global Erectile Dysfunction Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Erectile Dysfunction Drugs Market Size by Type
6.1.1 US & Canada Erectile Dysfunction Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Erectile Dysfunction Drugs Revenue by Type (2018-2029)
6.2 US & Canada Erectile Dysfunction Drugs Market Size by Application
6.2.1 US & Canada Erectile Dysfunction Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Erectile Dysfunction Drugs Revenue by Application (2018-2029)
6.3 US & Canada Erectile Dysfunction Drugs Market Size by Country
6.3.1 US & Canada Erectile Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Erectile Dysfunction Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Erectile Dysfunction Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Erectile Dysfunction Drugs Market Size by Type
7.1.1 Europe Erectile Dysfunction Drugs Sales by Type (2018-2029)
7.1.2 Europe Erectile Dysfunction Drugs Revenue by Type (2018-2029)
7.2 Europe Erectile Dysfunction Drugs Market Size by Application
7.2.1 Europe Erectile Dysfunction Drugs Sales by Application (2018-2029)
7.2.2 Europe Erectile Dysfunction Drugs Revenue by Application (2018-2029)
7.3 Europe Erectile Dysfunction Drugs Market Size by Country
7.3.1 Europe Erectile Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Erectile Dysfunction Drugs Sales by Country (2018-2029)
7.3.3 Europe Erectile Dysfunction Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Erectile Dysfunction Drugs Market Size
8.1.1 China Erectile Dysfunction Drugs Sales (2018-2029)
8.1.2 China Erectile Dysfunction Drugs Revenue (2018-2029)
8.2 China Erectile Dysfunction Drugs Market Size by Application
8.2.1 China Erectile Dysfunction Drugs Sales by Application (2018-2029)
8.2.2 China Erectile Dysfunction Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Erectile Dysfunction Drugs Market Size by Type
9.1.1 Asia Erectile Dysfunction Drugs Sales by Type (2018-2029)
9.1.2 Asia Erectile Dysfunction Drugs Revenue by Type (2018-2029)
9.2 Asia Erectile Dysfunction Drugs Market Size by Application
9.2.1 Asia Erectile Dysfunction Drugs Sales by Application (2018-2029)
9.2.2 Asia Erectile Dysfunction Drugs Revenue by Application (2018-2029)
9.3 Asia Erectile Dysfunction Drugs Sales by Region
9.3.1 Asia Erectile Dysfunction Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Erectile Dysfunction Drugs Revenue by Region (2018-2029)
9.3.3 Asia Erectile Dysfunction Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Erectile Dysfunction Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Erectile Dysfunction Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Eli Lilly Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Pfizer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Overview
11.3.3 Bayer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Bayer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 BaiYunShan General Factory
11.4.1 BaiYunShan General Factory Company Information
11.4.2 BaiYunShan General Factory Overview
11.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BaiYunShan General Factory Recent Developments
11.5 S.K. Chemicals
11.5.1 S.K. Chemicals Company Information
11.5.2 S.K. Chemicals Overview
11.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 S.K. Chemicals Recent Developments
11.6 Teva Pharma
11.6.1 Teva Pharma Company Information
11.6.2 Teva Pharma Overview
11.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Teva Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharma Recent Developments
11.7 Dong-A ST
11.7.1 Dong-A ST Company Information
11.7.2 Dong-A ST Overview
11.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Dong-A ST Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dong-A ST Recent Developments
11.8 Metuchen Pharma
11.8.1 Metuchen Pharma Company Information
11.8.2 Metuchen Pharma Overview
11.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Metuchen Pharma Recent Developments
11.9 Seoul Pharma
11.9.1 Seoul Pharma Company Information
11.9.2 Seoul Pharma Overview
11.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Seoul Pharma Recent Developments
11.10 CSBIO.
11.10.1 CSBIO. Company Information
11.10.2 CSBIO. Overview
11.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 CSBIO. Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSBIO. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Erectile Dysfunction Drugs Industry Chain Analysis
12.2 Erectile Dysfunction Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Erectile Dysfunction Drugs Production Mode & Process
12.4 Erectile Dysfunction Drugs Sales and Marketing
12.4.1 Erectile Dysfunction Drugs Sales Channels
12.4.2 Erectile Dysfunction Drugs Distributors
12.5 Erectile Dysfunction Drugs Customers
13 Market Dynamics
13.1 Erectile Dysfunction Drugs Industry Trends
13.2 Erectile Dysfunction Drugs Market Drivers
13.3 Erectile Dysfunction Drugs Market Challenges
13.4 Erectile Dysfunction Drugs Market Restraints
14 Key Findings in The Global Erectile Dysfunction Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Erectile Dysfunction Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Sildenafil
Table 3. Major Manufacturers of Tadalafil
Table 4. Major Manufacturers of Others
Table 5. Global Erectile Dysfunction Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Erectile Dysfunction Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Erectile Dysfunction Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Erectile Dysfunction Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2018-2023)
Table 10. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2024-2029)
Table 11. Global Erectile Dysfunction Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Erectile Dysfunction Drugs Sales by Region (2018-2023) & (M Pill)
Table 13. Global Erectile Dysfunction Drugs Sales by Region (2024-2029) & (M Pill)
Table 14. Global Erectile Dysfunction Drugs Sales Market Share by Region (2018-2023)
Table 15. Global Erectile Dysfunction Drugs Sales Market Share by Region (2024-2029)
Table 16. Global Erectile Dysfunction Drugs Sales by Manufacturers (2018-2023) & (M Pill)
Table 17. Global Erectile Dysfunction Drugs Sales Share by Manufacturers (2018-2023)
Table 18. Global Erectile Dysfunction Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Erectile Dysfunction Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Erectile Dysfunction Drugs Price by Manufacturers 2018-2023 (USD/Pill)
Table 22. Global Erectile Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Drugs as of 2022)
Table 24. Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Erectile Dysfunction Drugs, Product Offered and Application
Table 26. Global Key Manufacturers of Erectile Dysfunction Drugs, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Erectile Dysfunction Drugs Sales by Type (2018-2023) & (M Pill)
Table 29. Global Erectile Dysfunction Drugs Sales by Type (2024-2029) & (M Pill)
Table 30. Global Erectile Dysfunction Drugs Sales Share by Type (2018-2023)
Table 31. Global Erectile Dysfunction Drugs Sales Share by Type (2024-2029)
Table 32. Global Erectile Dysfunction Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Erectile Dysfunction Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Erectile Dysfunction Drugs Revenue Share by Type (2018-2023)
Table 35. Global Erectile Dysfunction Drugs Revenue Share by Type (2024-2029)
Table 36. Erectile Dysfunction Drugs Price by Type (2018-2023) & (USD/Pill)
Table 37. Global Erectile Dysfunction Drugs Price Forecast by Type (2024-2029) & (USD/Pill)
Table 38. Global Erectile Dysfunction Drugs Sales by Application (2018-2023) & (M Pill)
Table 39. Global Erectile Dysfunction Drugs Sales by Application (2024-2029) & (M Pill)
Table 40. Global Erectile Dysfunction Drugs Sales Share by Application (2018-2023)
Table 41. Global Erectile Dysfunction Drugs Sales Share by Application (2024-2029)
Table 42. Global Erectile Dysfunction Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Erectile Dysfunction Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Erectile Dysfunction Drugs Revenue Share by Application (2018-2023)
Table 45. Global Erectile Dysfunction Drugs Revenue Share by Application (2024-2029)
Table 46. Erectile Dysfunction Drugs Price by Application (2018-2023) & (USD/Pill)
Table 47. Global Erectile Dysfunction Drugs Price Forecast by Application (2024-2029) & (USD/Pill)
Table 48. US & Canada Erectile Dysfunction Drugs Sales by Type (2018-2023) & (M Pill)
Table 49. US & Canada Erectile Dysfunction Drugs Sales by Type (2024-2029) & (M Pill)
Table 50. US & Canada Erectile Dysfunction Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Erectile Dysfunction Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Erectile Dysfunction Drugs Sales by Application (2018-2023) & (M Pill)
Table 53. US & Canada Erectile Dysfunction Drugs Sales by Application (2024-2029) & (M Pill)
Table 54. US & Canada Erectile Dysfunction Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Erectile Dysfunction Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Erectile Dysfunction Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Erectile Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Erectile Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Erectile Dysfunction Drugs Sales by Country (2018-2023) & (M Pill)
Table 60. US & Canada Erectile Dysfunction Drugs Sales by Country (2024-2029) & (M Pill)
Table 61. Europe Erectile Dysfunction Drugs Sales by Type (2018-2023) & (M Pill)
Table 62. Europe Erectile Dysfunction Drugs Sales by Type (2024-2029) & (M Pill)
Table 63. Europe Erectile Dysfunction Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Erectile Dysfunction Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Erectile Dysfunction Drugs Sales by Application (2018-2023) & (M Pill)
Table 66. Europe Erectile Dysfunction Drugs Sales by Application (2024-2029) & (M Pill)
Table 67. Europe Erectile Dysfunction Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Erectile Dysfunction Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Erectile Dysfunction Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Erectile Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Erectile Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Erectile Dysfunction Drugs Sales by Country (2018-2023) & (M Pill)
Table 73. Europe Erectile Dysfunction Drugs Sales by Country (2024-2029) & (M Pill)
Table 74. China Erectile Dysfunction Drugs Sales by Type (2018-2023) & (M Pill)
Table 75. China Erectile Dysfunction Drugs Sales by Type (2024-2029) & (M Pill)
Table 76. China Erectile Dysfunction Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Erectile Dysfunction Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Erectile Dysfunction Drugs Sales by Application (2018-2023) & (M Pill)
Table 79. China Erectile Dysfunction Drugs Sales by Application (2024-2029) & (M Pill)
Table 80. China Erectile Dysfunction Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Erectile Dysfunction Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Erectile Dysfunction Drugs Sales by Type (2018-2023) & (M Pill)
Table 83. Asia Erectile Dysfunction Drugs Sales by Type (2024-2029) & (M Pill)
Table 84. Asia Erectile Dysfunction Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Erectile Dysfunction Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Erectile Dysfunction Drugs Sales by Application (2018-2023) & (M Pill)
Table 87. Asia Erectile Dysfunction Drugs Sales by Application (2024-2029) & (M Pill)
Table 88. Asia Erectile Dysfunction Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Erectile Dysfunction Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Erectile Dysfunction Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Erectile Dysfunction Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Erectile Dysfunction Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Erectile Dysfunction Drugs Sales by Region (2018-2023) & (M Pill)
Table 94. Asia Erectile Dysfunction Drugs Sales by Region (2024-2029) & (M Pill)
Table 95. Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Type (2018-2023) & (M Pill)
Table 96. Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Type (2024-2029) & (M Pill)
Table 97. Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Application (2018-2023) & (M Pill)
Table 100. Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Application (2024-2029) & (M Pill)
Table 101. Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Country (2018-2023) & (M Pill)
Table 107. Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales by Country (2024-2029) & (M Pill)
Table 108. Eli Lilly Company Information
Table 109. Eli Lilly Description and Major Businesses
Table 110. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 111. Eli Lilly Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Eli Lilly Recent Developments
Table 113. Pfizer Company Information
Table 114. Pfizer Description and Major Businesses
Table 115. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 116. Pfizer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Pfizer Recent Developments
Table 118. Bayer Company Information
Table 119. Bayer Description and Major Businesses
Table 120. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 121. Bayer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Bayer Recent Developments
Table 123. BaiYunShan General Factory Company Information
Table 124. BaiYunShan General Factory Description and Major Businesses
Table 125. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 126. BaiYunShan General Factory Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. BaiYunShan General Factory Recent Developments
Table 128. S.K. Chemicals Company Information
Table 129. S.K. Chemicals Description and Major Businesses
Table 130. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 131. S.K. Chemicals Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. S.K. Chemicals Recent Developments
Table 133. Teva Pharma Company Information
Table 134. Teva Pharma Description and Major Businesses
Table 135. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 136. Teva Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Teva Pharma Recent Developments
Table 138. Dong-A ST Company Information
Table 139. Dong-A ST Description and Major Businesses
Table 140. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 141. Dong-A ST Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Dong-A ST Recent Developments
Table 143. Metuchen Pharma Company Information
Table 144. Metuchen Pharma Description and Major Businesses
Table 145. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 146. Metuchen Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Metuchen Pharma Recent Developments
Table 148. Seoul Pharma Company Information
Table 149. Seoul Pharma Description and Major Businesses
Table 150. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 151. Seoul Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Seoul Pharma Recent Developments
Table 153. CSBIO. Company Information
Table 154. CSBIO. Description and Major Businesses
Table 155. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
Table 156. CSBIO. Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. CSBIO. Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Erectile Dysfunction Drugs Distributors List
Table 161. Erectile Dysfunction Drugs Customers List
Table 162. Erectile Dysfunction Drugs Market Trends
Table 163. Erectile Dysfunction Drugs Market Drivers
Table 164. Erectile Dysfunction Drugs Market Challenges
Table 165. Erectile Dysfunction Drugs Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Erectile Dysfunction Drugs Product Picture
Figure 2. Global Erectile Dysfunction Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Erectile Dysfunction Drugs Market Share by Type in 2022 & 2029
Figure 4. Sildenafil Product Picture
Figure 5. Tadalafil Product Picture
Figure 6. Others Product Picture
Figure 7. Global Erectile Dysfunction Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Erectile Dysfunction Drugs Market Share by Application in 2022 & 2029
Figure 9. Hospital Pharmacies
Figure 10. Private Clinics
Figure 11. Retail Pharmacies
Figure 12. E-Commerce (B2B)
Figure 13. E-Commerce (B2C)
Figure 14. Erectile Dysfunction Drugs Report Years Considered
Figure 15. Global Erectile Dysfunction Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Erectile Dysfunction Drugs Revenue 2018-2029 (US$ Million)
Figure 17. Global Erectile Dysfunction Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2018-2029)
Figure 19. Global Erectile Dysfunction Drugs Sales 2018-2029 ((M Pill)
Figure 20. Global Erectile Dysfunction Drugs Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Erectile Dysfunction Drugs Sales YoY (2018-2029) & (M Pill)
Figure 22. US & Canada Erectile Dysfunction Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Erectile Dysfunction Drugs Sales YoY (2018-2029) & (M Pill)
Figure 24. Europe Erectile Dysfunction Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Erectile Dysfunction Drugs Sales YoY (2018-2029) & (M Pill)
Figure 26. China Erectile Dysfunction Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Erectile Dysfunction Drugs Sales YoY (2018-2029) & (M Pill)
Figure 28. Asia (excluding China) Erectile Dysfunction Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Erectile Dysfunction Drugs Sales YoY (2018-2029) & (M Pill)
Figure 30. Middle East, Africa and Latin America Erectile Dysfunction Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Erectile Dysfunction Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Erectile Dysfunction Drugs in the World: Market Share by Erectile Dysfunction Drugs Revenue in 2022
Figure 33. Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Erectile Dysfunction Drugs Sales Market Share by Type (2018-2029)
Figure 35. Global Erectile Dysfunction Drugs Revenue Market Share by Type (2018-2029)
Figure 36. Global Erectile Dysfunction Drugs Sales Market Share by Application (2018-2029)
Figure 37. Global Erectile Dysfunction Drugs Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Erectile Dysfunction Dr
  • Global Testosterone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Testosterone Replacement Therapy market size was valued at US$ 1493.3 million in 2023. With growing demand in downstream market, the Testosterone Replacement Therapy is forecast to a readjusted size of US$ 1101.6 million by 2030 with a CAGR of -4.3% during review period. The research report highlights the growth potential of the global Testosterone Replacement Therapy market. Testosterone Replacement Therapy are expected to s......
  • Global Finasteride Tablets Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The Finasteride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Finasteride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Global Erectile Dysfunction Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Erectile Dysfunction Drugs market size was valued at US$ 4749.4 million in 2023. With growing demand in downstream market, the Erectile Dysfunction Drugs is forecast to a readjusted size of US$ 7247.8 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Erectile Dysfunction Drugs market. Erectile Dysfunction Drugs are expected to show stable growth in the ......
  • Global Methyltestosterone Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 75
    The Methyltestosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methyltestosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles......
  • Global Tamsulosin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Tamsulosin market: According to our latest research, the global Tamsulosin market looks promising in the next 5 years. As of 2022, the global Tamsulosin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Tamsulosin market, with a systematical de......
  • Global Erectile Dysfunction Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Erectile Dysfunction Drug market: According to our latest research, the global Erectile Dysfunction Drug market looks promising in the next 5 years. As of 2022, the global Erectile Dysfunction Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Finasteride Tablets Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Finasteride Tablets market: According to our latest research, the global Finasteride Tablets market looks promising in the next 5 years. As of 2022, the global Finasteride Tablets market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Finasteride Ta......
  • Finasteride Tablets - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 106
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Finasteride Tablets, with both quantit......
  • Global Duchenne Muscular Dystrophy Drugs Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 134
    Report Overview: The Global Duchenne Muscular Dystrophy Drugs Market Size was estimated at USD 8086.70 million in 2022 and is projected to reach USD 62734.28 million by 2029, exhibiting a CAGR of 34.00% during the forecast period. This report provides a deep insight into the global Duchenne Muscular Dystrophy Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs